PRODUCTS
ZytoLight ® Bladder Cancer Quadruple Color Probe
The ZytoLight ® Bladder Cancer Quadruple Color Probe is designed to detect CDKN2A (a.k.a. p16) deletions and aneuploidy of chromosomes 3, 7, and 17 in cytology specimens of tumors, e.g., in urine samples from patients with hematuria suspected of having bladder cancer (BC). Moreover, it has been shown that the detection of CDKN2A deletions and/or aneusomies of chromosomes 3, 7, and/or 17 may be used for the surveillance of patients with a history of bladder cancer to early detect possible tumor recurrence.
Probe Maps
Ordering Information
| Prod. No.: | Tests¹ (Volume): | Intended Use²: | ||
|---|---|---|---|---|
| Z-2305-50 |
|
 |
||
| Z-2305-200 |
|
|
Download Information
Flyer
| 1 | Using 10 μl probe solution per test. |
| 2 | In vitro diagnostic medical device according to EU directive 98/79/EC. CE IVD only available in certain countries. All other countries research use only! Please contact your local dealer for more information. |
